COVID-19 Boosters for Immunocompromised People

Recently there has been a rise in global coronavirus cases, and this reinforced the need to find ways to protect the millions of immunocompromised people. Immunocompromised people are individuals with weaker immune systems and are at high risks for many diseases. They often don’t mound as strong defenses against the COVID-19 virus even when they are fully vaccinated. In the United States, there is an estimate of 2.7 percent of the adult population, or 6.8 million people to be more exact, that are immunocompromised. To solve this issue, some scientists have said a third COVID-19 vaccine may help protect some of these special types of people in need of more help than others. Because the idea has been newly suggested, there are not enough data, and as of now, we cannot be sure of how much the third vaccine helps or if it helps at all. Therefore the agency is not yet recommending a third dose and that even the vaccinated people in this group should continue to wear their masks.
Many of the individuals in this immunocompromised group of people are those such as organ transplant recipients and cancer patients, but the rest could be just ordinary people with slightly less effective immune systems than other people. Out of 45 vaccinated people, 20 people, or 44 percent of the population, are immunocompromised.
Even though the scientist is not a hundred percent sure and does not suggest the third vaccine just yet, it has been brought up by the laboratory studies that the third vaccine could possibly boost coronavirus-fighting antibodies in the blood. What is unclear yet is if a specific group will benefit more than others from this vaccine and how effective the third vaccine would be. One thing confirmed and tested, however, is that the third vaccine is not dangerous for immunocompromised people. Those who have received their third vaccine (including patients on dialysis for kidney disease) have said that the symptoms of their third vaccine were similar to those they received from the first two vaccines.
While America is struggling to come up with a conclusion to this new method, some of the other countries have already come up with ways to help the immunocompromised people. I think this should be a signal for the U.S. to try a little harder and work a little faster to be able to help the ones in need as soon as possible.

Categories: Society